Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080812 | SCV000112714 | benign | not specified | 2015-03-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080812 | SCV000168147 | benign | not specified | 2014-03-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000080812 | SCV000268976 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.His2921Arg in exon 59 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 3% (200/6728) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS/; dbSNP rs1800279). |
Prevention |
RCV004528101 | SCV000309949 | benign | DMD-related disorder | 2019-05-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ambry Genetics | RCV000242837 | SCV000318282 | benign | Cardiovascular phenotype | 2015-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000355558 | SCV000482223 | benign | Dilated cardiomyopathy 3B | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000458193 | SCV000560811 | benign | Duchenne muscular dystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529480 | SCV000603333 | benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080812 | SCV001364029 | benign | not specified | 2019-02-18 | criteria provided, single submitter | clinical testing | Variant summary: DMD c.8762A>G (p.His2921Arg) results in a non-conservative amino acid change located in a spectrin repeat (IPR018159) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.026 in 200041 control chromosomes in the gnomAD database, including 42 homozygotes and 1923 hemizygotes. These data strongly suggest that the variant is benign. Six ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as benign (5x) and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome- |
RCV000458193 | SCV001653414 | likely benign | Duchenne muscular dystrophy | 2021-05-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000012020 | SCV000032254 | uncertain significance | Becker muscular dystrophy | 1994-09-01 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV001529480 | SCV001743010 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000080812 | SCV001797734 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000080812 | SCV001926080 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000080812 | SCV001931083 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826458 | SCV002080242 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-03-28 | no assertion criteria provided | clinical testing |